Liver Research Group, Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
Centenary Institute of Cancer Medicine, Royal Prince Alfred Hospital, Camperdown, Australia; Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia; Central Clinical School, The University of Sydney, Camperdown, Australia.
Gastroenterology. 2016 Jun;150(8):1728-1744.e7. doi: 10.1053/j.gastro.2016.01.037. Epub 2016 Feb 10.
Genome-wide association studies and candidate gene studies have informed our understanding of factors contributing to the well-recognized interindividual variation in the progression and outcomes of alcoholic liver disease and nonalcoholic fatty liver disease. We discuss the mounting evidence for shared modifiers and common pathophysiological processes that contribute to development of both diseases. We discuss the functions of proteins encoded by risk variants of genes including patatin-like phospholipase domain-containing 3 and transmembrane 6 superfamily member 2, as well as epigenetic factors that contribute to the pathogenesis of alcoholic liver disease and nonalcoholic fatty liver disease. We also discuss important areas of future genetic research and their potential to affect clinical management of patients.
全基因组关联研究和候选基因研究使我们了解了导致酒精性肝病和非酒精性脂肪性肝病的进展和结局存在个体间差异的因素。我们讨论了越来越多的共同修饰因子和共同病理生理过程的证据,这些因素导致了这两种疾病的发生。我们讨论了编码 patatin-like phospholipase domain-containing 3 和跨膜 6 超家族成员 2 等风险变异基因的蛋白质以及导致酒精性肝病和非酒精性脂肪性肝病发病机制的表观遗传因素的功能。我们还讨论了未来遗传研究的重要领域及其对患者临床管理的潜在影响。